Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $59,940 - $118,664
13,500 New
13,500 $61,000
Q1 2023

May 15, 2023

BUY
$5.53 - $8.22 $3.6 Million - $5.36 Million
651,664 New
651,664 $3.98 Million
Q2 2020

Aug 14, 2020

SELL
$27.21 - $41.0 $1.23 Million - $1.85 Million
-45,205 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$19.54 - $38.85 $883,305 - $1.76 Million
45,205 New
45,205 $1.35 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.17B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.